Gilead Sciences Price target raised Strong Buy - major shareholder Kite Pharma since $45 Strong Buy
Former short position closed reversing to the long side after capitulation
Former short position closed reversing to the long side after capitulation
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.